Global Alzheimer's Marketing Director

UCB; Boston (MA); Hybrid; USD 184,000 - 242,000; Full time

Job summary

UCB seeks a strategic, insights-driven Global Alzheimer’s Disease Marketing Lead (Director-level) to join the Stakeholder Integration team. Based in a U.S.

hub (Boston, Atlanta, or Raleigh), this hybrid role focuses on shaping commercialization for a post-proof-of-concept asset in Alzheimer’s disease. You will build market understanding across patients, caregivers, and providers, and translate insights into asset strategy.

Qualifications

• Bachelor’s degree required.
• 10+ years pharmaceutical strategy, marketing, or commercialization experience.
• 2+ years direct Alzheimer’s disease or dementia experience.
• 2+ years supporting a post-proof-of-concept or pre-launch asset.

Responsibilities

• Shape commercialization of a post-proof-of-concept asset in Alzheimer’s disease.
• Lead global cross-functional forum for learning, collaboration and commercial decision making.
• Develop patient population vision, value proposition, positioning and commercialization strategy.
• Define market-development priorities to support future adoption across diagnosis and pathways.
• Create market assessments, forecasts, business cases and scenarios.
• Evaluate development and partnering options through commercial assessment of risks and opportunities.
• Translate external stakeholder perspectives into clear asset recommendations.

Skills

Pharma marketing

Strategic planning

Cross-functional collaboration

Commercialization experience

Alzheimer’s disease experience

Development-stage asset experience

Education

Bachelor’s degree

Job description

UCB seeks a strategic, insights-driven Global Alzheimer’s Disease Marketing Lead (Director-level) to join the Stakeholder Integration team. Based in a U.S.

hub (Boston, Atlanta, or Raleigh), this hybrid role focuses on shaping commercialization for a post-proof-of-concept asset in Alzheimer’s disease. You will build market understanding across patients, caregivers, and providers, and translate insights into asset strategy.